Imagine you could simply generate an entire EIC Accelerator application based on a single company file and a few prompts. ChatEIC, a custom AI based on GPT-4, is able to do exactly just that. EIC Accelerator Modules The EIC Accelerator Training Program utilizes a Module-based approach to grant writing where specific sections are combined into Modules to facilitate the learning and writing process. Using the same approach for teaching companies how to write a grant application and apply for the EIC Accelerator, ChatEIC is able to learn how each section must be structured and can simply apply its learnings to any company. In this scenario, the user has to provide only minimal input, if any. Ideally, the user only needs to upload an investor deck or a long pitch deck and ChatEIC will take it from there. The Case Study: Generating Proposal Sections As an example, one can use publically available data such as an investor deck by the publically-traded synthetic biology company Ginkgo Bioworks. While this deck is by no means complete, it contains 66 pages of valuable information and, most importantly, describes a DeepTech project that is very much aligned with the EIC Accelerator. Ginkgo Bioworks, while it is a US business, is an excellent case study to test the capabilities of AI-generated grant proposal sections since the main performance standard for any AI grant writer is minimum input. Using an AI text generator is only useful if it reduces the workload which makes minimal prompt work a must. Now, let’s see how well ChatEIC will perform with its general knowledge regarding the writing of EIC Accelerator proposals. A major challenge is to turn general knowledge into specialized knowledge since each company, market and industry are different. So, is ChatEIC able to create specialized sections or will it end up being generic? Example: Market, Abstract and Risks Note: The modules contain pre-defined context that ChatEIC will recognize and use to write for this project. ChatEIC does not need to be reminded what each Module means since it knows them by heart and just needs to hear the number. In this case, the first input prompt only contains the Ginkgo Bioworks Investor Deck as a PDF attachment. The following chat conversation represents the entire conversation, prompts and information exchanged with ChatEIC without any edits or omissions. ChatEIC has no prior knowledge regarding grant applications for Ginkgo Bioworks or specialized knowledge of synthetic biology companies outside of the GPT-4 base. Input: Write Module 56 (Ginkgo.PDF attached) ChatEIC: After reviewing the document provided, I didn’t find specific information related to Market Size & Growth (Module 56) for Ginkgo. However, based on the nature of Ginkgo’s work and industry, I can draft a generic Module 56 for your review. Module 56: Market Size & Growth Market Size and Compound Annual Growth Rate (CAGR) Ginkgo operates in the rapidly evolving biotechnology sector, focusing on cell programming and bioengineering. The Total Addressable Market (TAM) for the global biotech industry is estimated to be over €XX billion, driven by increasing demand for innovative healthcare solutions, sustainable agricultural practices, and novel bio-based products. Serviceable Addressable Market (SAM) Within this broad market, Ginkgo’s SAM can be segmented into specialized areas like synthetic biology, genome engineering, and biosecurity, totaling around €XX billion. This segment is characterized by a robust growth trajectory due to technological advancements and increasing adoption of bioengineered solutions across various industries. Serviceable Obtainable Market (SOM) Ginkgo’s SOM, considering its current product and service offerings, is projected to be in the range of €XX million to €XX million. The company is well-positioned to capture a significant portion of this market, given its innovative platform, strategic partnerships, and advanced capabilities in cell programming. Market Trends and Future Outlook The market is witnessing a significant shift towards sustainable and environmentally friendly solutions, where Ginkgo’s expertise in bioengineering is highly relevant. Upcoming regulatory changes, increased investment in biotech research, and a growing focus on personalized medicine and sustainable practices are likely to further drive market growth. Ginkgo’s ability to adapt and innovate positions it favorably to leverage these trends for sustained growth. This module is a general depiction based on the typical market environment for companies like Ginkgo. For a more accurate and detailed module, specific market data and growth projections related to Ginkgo’s products and services are required. Do you have any additional information or specific data points that you would like to include in this module? Input: Use Bing to search for market reports for the SAM and SOM as well in the broader synthetic biology space ChatEIC: Based on a quick search, here’s what I discovered. The search for specific market reports on the Serviceable Addressable Market (SAM) and Serviceable Obtainable Market (SOM) in the synthetic biology space for 2024 didn’t yield precise results. The available information primarily covers the overall Synthetic Biology Market. Here’s what I found: The Synthetic Biology Market size is estimated to be USD 79.39 billion in 2024 and is expected to reach USD 145.49 billion by 2029, growing at a CAGR of 12.88% during the forecast period (2024-2029).[ref] According to another report, the Synthetic Biology Market was valued at USD 13.1 billion in 2022 and is projected to expand at a significant growth rate.[ref] A different source mentions that the global synthetic biology market size was valued at USD 13.09 billion in 2022 and is expected to expand at a CAGR of 18.97% from 2023 to 2030.[ref] One more report supports the estimation of the Synthetic Biology Market size at USD 79.39 billion in 2024, with a growth forecast up to USD 145.49 billion by 2029.[ref] Lastly, another study valued the Synthetic Biology Market at USD 9.4 billion in 2022 and expected it to reach USD 47.4 billion by 2029, with a CAGR of 26% during the forecast period 2023-29.[ref] These findings provide a broad overview of the market size and growth rate in the synthetic biology sector. However, for a more precise estimation of SAM and SOM for Ginkgo … Read more
